Right patient, right treatment, right time: biosignatures and precision medicine in depression

World Psychiatry

Volumn 15, Issue 3, 2016, Pages 237-238

  Trivedi, Madhukar H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL FACTOR; DEXAMETHASONE;

BLOOD BRAIN BARRIER; BRAIN FUNCTION; CLINICAL DECISION MAKING; COMORBIDITY; DEPRESSION; DIFFUSION TENSOR IMAGING; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HEART DISEASE; HUMAN; NOTE; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

EID: 84988434122     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20371     Document Type: Note

References (10)

1. Kapur S, Phillips AG, Insel TR. Mol Psychiatry 2012;17:1174-9.
2. Rush AJ, Trivedi MH, Wisniewski SR et al. Am J Psychiatry 2006;163:1905-17.
3. Trivedi MH, Rush AJ, Wisniewski SR et al. Am J Psychiatry 2006;163:28-40.
4. Roychowdhury S, Chinnaiyan AM. Annu Rev Genomics Hum Genet 2014;15:395-415.
5. Biswal BB, Mennes M, Zuo XN et al. Proc Natl Acad Sci USA 2010;107:4734-9.
6. Rush AJ, Giles DE, Schlesser MA et al. J Clin Psychiatry 1996;57:470-84.
7. Biernacka JM, Sangkuhl K, Jenkins G et al. Transl Psychiatry 2015;5:e553.
8. Smith DF. Front Psychiatry 2013;4:57.
9. Trivedi MH. Biol Psychiatry 2013;74:2-4.
10. Trivedi MH, McGrath PJ, Fava M et al. J Psychiatr Res 2016;78:11-23.